CD144 dysregulation contributes to endothelial dysfunction in hypertension, exacerbates tissue damage during ischemia-reperfusion injury, and impairs vascular function in heart failure.8,9 As a biomarker, CD144 offers significant potential for the early detection and monitoring of CVD. This evidence concerns the gene CDH5 and heart failure.